| Date Filed | Type | Description |
| 02/03/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2022 |
4
| Ostertag Eric (Executive Chairman) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Bought 142,857 shares
@ $3.5, valued at
$500k
|
|
| 08/05/2022 |
4
| Ostertag Eric (Executive Chairman) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Sold 160,696 shares
@ $3.689, valued at
$592.8k
|
|
| 02/01/2022 |
4
| Ostertag Eric (Executive Chairman) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Gifted 93,955 shares
@ $0
Gifted 48,902 shares
@ $0
Granted 89,500 shares
@ $0
Granted 118,708 options to buy
@ $4.75, valued at
$563.9k
Granted 10,792 options to buy
@ $0 |
|
| 11/22/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Exercised 1,000 options to buy
@ $9.15, valued at
$9.2k
|
|
| 11/10/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Sold 9,873 shares
@ $7.09, valued at
$70k
Sold 9,051 shares
@ $7.09, valued at
$64.2k
|
|
| 10/13/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/15/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/06/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Sold 10,729 shares
@ $9.77, valued at
$104.8k
Sold 104 shares
@ $9.65, valued at
$1k
Sold 14,266 shares
@ $8.9, valued at
$127k
Sold 9,834 shares
@ $9.77, valued at
$96.1k
Sold 96 shares
@ $9.65, valued at
$926.4
Sold 13,076 shares
@ $8.9, valued at
$116.4k
|
|
| 06/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/05/2021 |
3/A
| Form 3/A - Initial statement of beneficial ownership of securities: [Amend] |
| 04/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Sold 29,702 shares
@ $11.66, valued at
$346.3k
Sold 528 shares
@ $12.12, valued at
$6.4k
Sold 29,770 shares
@ $11.539, valued at
$343.5k
Sold 27,226 shares
@ $11.66, valued at
$317.5k
Sold 484 shares
@ $12.12, valued at
$5.9k
Sold 27,290 shares
@ $11.539, valued at
$314.9k
|
|
| 02/25/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Exercised 111,395 options to buy
@ $1.173, valued at
$130.7k
|
|
| 02/17/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Sold 133,149 shares
@ $10.0041, valued at
$1.3M
|
|
| 02/12/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Sold 12,389 shares
@ $10, valued at
$123.9k
Exercised 67,534 options to buy
@ $1.29, valued at
$87.1k
|
|
| 02/05/2021 |
4
| Ostertag Eric (CEO) has filed a Form 4 on Poseida Therapeutics, Inc.|
Txns:
| Granted 889,193 options to buy
@ $9.15, valued at
$8.1M
|
|
| 01/25/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2020 |
3
| Ostertag Eric (CEO) has filed a Form 3 on Poseida Therapeutics, Inc. |